APA (7th ed.) Citation

Kim, S., Chen, D., Stone, B., Al-Rashdan, A., Elsaka, R., Torres-Roca, J., . . . Stevens, C. (2015). The Lung Metastasis Risk (LMR) Signature: A Prognostic Genomic Biomarker Predicting Distant Failure Among Stage I Adenocarcinoma Patients Following Local Therapy. International Journal of Radiation Oncology, Biology, Physics, 93(3), S67. https://doi.org/10.1016/j.ijrobp.2015.07.160

Chicago Style (17th ed.) Citation

Kim, S., et al. "The Lung Metastasis Risk (LMR) Signature: A Prognostic Genomic Biomarker Predicting Distant Failure Among Stage I Adenocarcinoma Patients Following Local Therapy." International Journal of Radiation Oncology, Biology, Physics 93, no. 3 (2015): S67. https://doi.org/10.1016/j.ijrobp.2015.07.160.

MLA (9th ed.) Citation

Kim, S., et al. "The Lung Metastasis Risk (LMR) Signature: A Prognostic Genomic Biomarker Predicting Distant Failure Among Stage I Adenocarcinoma Patients Following Local Therapy." International Journal of Radiation Oncology, Biology, Physics, vol. 93, no. 3, 2015, p. S67, https://doi.org/10.1016/j.ijrobp.2015.07.160.